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SUMMARY
Purpose: Several studies have indicated that psychogenic
nonepileptic seizures (PNES) are associated with psycho-
logical trauma, but only a few studies have examined the
associations with neurobiologic stress systems, such as
the hypothalamus–pituitary–adrenal (HPA) axis and its
end-product cortisol. We tested several relevant HPA-
axis functions in patients with PNES and related them to
trauma history.
Methods: Cortisol awakening curve, basal diurnal cortisol,
and negative cortisol feedback (using a 1 mg dexametha-
sone suppression test) were examined in 18 patients with
PNES and 19 matched healthy controls (HCs) using saliva
cortisol sampling on two consecutive days at 19 time
points. Concomitant sympathetic nervous system (SNS)
activity was assessed by analyzing saliva a-amylase (sAA).
Results: Patients with PNES showed significantly increa-
sed basal diurnal cortisol levels compared to HCs. This
effect was driven mainly by patients reporting sexual
trauma who showed a trend toward higher cortisol levels
as compared to patients without a sexual trauma report.
Importantly, the increased basal diurnal cortisol levels in
patients were not explained by depression, medication, or
smoking, or by current seizures or group differences in
SNS activity.
Discussion: This is the first study showing that basal hy-
percortisolism in patients with PNES is independent of
the acute occurrence of seizures. In addition, basal hyper-
cortisolism was more pronounced in traumatized
patients with PNES as compared to nontraumatized
patients with PNES. These findings suggest that HPA-axis
activity provides a significant neurobiologic marker for
PNES.
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Several studies have indicated that psychogenic nonepi-
leptic seizures (PNES) are associated with a history of psy-
chological trauma, such as sexual and physical abuse (for
reviews see, e.g., Fiszman et al., 2004; Sharpe & Faye,
2006; Roelofs & Spinhoven, 2007). Only few studies have
investigated the association of PNES with neurobiologic
stress systems, such as the hypothalamus–pituitary–adrenal
(HPA) axis with cortisol as its end-product. The majority of
these studies focused on the effects of seizure-like activity
on cortisol levels and found mostly increased cortisol levels
in patients with PNES (as well as in confirmed epilepsy
patients) related to seizures (e.g., Mehta et al., 1994; Tunca
et al., 2000). So far, only two studies have investigated
basal activity of the HPA axis in PNES, and the results are
conflicting. Tunca et al. (1996) did not find increased basal
cortisol levels in a sample of 25 patients with conversion
disorder (including 20 patients with PNES) compared to
healthy controls (HCs) but did find decreased cortisol sup-
pression after dexamethasone administration. In contrast, in
a sample of eight patients with PNES, Tunca et al. (2000)
later observed increased morning serum cortisol levels at
baseline (an average time interval of 18 h had elapsed since
the last seizure). In addition, we found no indications for
increased stress-induced cortisol levels in patients with
PNES but, in line with previous notions of increased basal
activity of physiologic stress-related systems in patients
with PNES, we found decreased levels of basal heart rate
variability (Bakvis et al., 2009), often taken as an indication
of hyperarousal (see, e.g., Thayer & Brosschot, 2005, for a
review). In summary, previous accounts of HPA-axis activ-
ity in patients with PNES have shown mixed results, and
none of the previous studies has investigated the relation-
ship between interpersonal trauma and HPA-axis activity in
patients with PNES.
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In an attempt to establish a neurobiologic marker associ-
ated with PNES, the present study was designed to test sev-
eral relevant HPA-axis functions, including cortisol
awakening response (CAR), basal diurnal cortisol, and neg-
ative cortisol feedback (using a dexamethasone suppression
test, DST) in patients with PNES and to relate eventual find-
ings to the occurrence of seizures and trauma history. In
contrast to previous studies on basal HPA-axis activity in
patients with PNES, we used a stress-free noninvasive
method for measuring cortisol (saliva instead of blood:
Kirschbaum et al., 1993; Kirschbaum & Hellhammer,
1994), we tested only those patients whose diagnosis was
based on an ictal electroencephalography (EEG)–video reg-
istration of a typical seizure, and we controlled for current
depression, use of psychotropic medication, smoking, and
menstrual cycle. In addition, we checked whether eventual
alterations in HPA-axis activity were accompanied by con-
comitant group differences in activation of the sympathetic
nervous system (SNS) through salivary a-amylase (sAA),
which is indicative of acute stress (for reviews see Granger
et al., 2007; Rohleder & Nater, 2009).
Based on Tunca et al. (1996, 2000), we predicted that we
would find increased HPA-axis activity (as evidenced by
increased basal diurnal cortisol levels, increased CAR, and
increased post-DST cortisol) in patients with PNES com-
pared to HCs. Second, in accordance with an extensive body
of literature linking negative life experiences to long-lasting
increases in HPA-axis activity in both animals (e.g.
Sapolsky et al., 1997; Anisman et al., 1998) and humans
(for reviews see, e.g., Yehuda, 2006; Gunnar & Quevedo,
2008), and, in particular, in accordance with previous find-
ings suggesting that sexual trauma was related to increased
threat vigilance in patients with PNES (Bakvis et al., 2009),
we hypothesized that the expected increased HPA-axis
activity in patients with PNES would be related to sexual
trauma.
Methods
Participants
From March 2005 until April 2007, 20 patients with
PNES, who had been admitted to a tertiary epilepsy center,
were recruited by the attending neurologists. Inclusion crite-
ria were: (1) diagnosis of PNES based on an ictal video-
EEG recording of a typical seizure, (2) PNES characterized
by complete or partial loss of consciousness (specified as an
ictal diminished or loss of adequate responsiveness or
postictal memory impairment of the ictal event), (3) the
occurrence of at least two seizures in the year prior to the
experiment, (4) no history of concomitant epileptic seizures,
(5) no comorbid neurologic disease diagnosis, and (6) no
diagnosis of endocrine disorder(s). Two of the 20 patients
had to be excluded because of the occurrence of several
seizures during the test days and consequently missing val-
ues. The remaining 18 patient (7 male, 11 female) had a
mean age of 31.6 [standard deviation (SD) 10.8) years.
Demographic data, use of contraceptives, use of psychotro-
pic medication, smoking status, current comorbid DSM-IV
axis I diagnoses (assessed using the MINI: Mini-Interna-
tional Neuropsychiatric Interview Sheehan et al., 1998;
Van Vliet & de Beurs, 2007), self-reported interpersonal
traumatic experiences, seizure characteristics, and the
occurrence of seizures an hour preceding sampling on test
days are provided in Table 1. The healthy control (HC)
group was recruited through advertisements in local news-
papers. Inclusion criteria were (1) no psychiatric diagnosis,
(2) no medical disease diagnosis, (3) no neurologic disease
diagnosis, and (4) no use of medication.
One of the 20 HCs who participated in this study was
removed from analyses post hoc, due to extremely high cor-
tisol levels indicative of endocrinopathy and was advised to
contact her physician for assessment. The remaining 19
HCs (10 male, 9 female) had a mean age of 35.1 (SD 13.5)
years. Patients and HCs did not differ with respect to age,
gender, and use of contraceptives (Table 1). Slightly more
patients with PNES smoked and as expected, more patients
with PNES used psychotropic medication. Furthermore,
PNES patients reported higher rates of sexual trauma and
overall interpersonal trauma compared to the control group
(see Table 1 for statistics).
Measures
Cortisol and a-amylase
Saliva samples for cortisol assessments were obtained
using Salivette collection devices with a cotton roll
(Sarstedt, Rommelsdorf, Germany). In total, 19 samples
were taken over two consecutive days. The salivary samples
on day 1 were taken at the time of awakening and 15, 30, 45,
and 60 min afterwards (cortisol awakening response, CAR)
and at 10:00 h, 12:00 h, 14:00 h 16:00 h, 18:00 h, 20:00 h,
and 22:00 h (basal diurnal cortisol). Participants were
instructed to take a tablet of dexamethasone (1 mg) at
23:00 h on day 1. The following day, participants collected
salivary samples again at the time of awakening and 15, 30,
45, and 60 min afterwards and at 16:00 h and 22:00 h (post-
DST cortisol). Saliva samples were stored at )20C before
assaying. Biochemical analysis of free cortisol in saliva was
performed using a competitive electrochemiluminescence
immunoassay (ECLIA, Elecsys 2010, Roche Diagnostics,
Basel, Switzerland), as described elsewhere (Van Aken
et al., 2003).
To check whether eventual alterations in HPA-axis activ-
ity were accompanied by concomitant group differences in
SNS activation, a-amylase levels were also analyzed from
these saliva samples. a-Amylase levels have been shown to
reflect SNS activity (for reviews see Granger et al., 2007;
Rohleder & Nater, 2009). Biochemical analysis of sAA was
performed using a kinetic maltotrioside method (CNP-G3;
DiaSys Diagnostic Systems, Holzheim, Germany) at
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405 nm for serum on a Vitalab Selectra (Merck, Darmstadt,
Germany) after dilution of saliva with saline (25 lL saliva
plus 10 mL saline). The detection limit for the method in
serum (or diluted saliva) was 2 U/L. The intraassay variabil-
ity coefficient was 1.6% at 411 U/L (n = 10); the interassay
variability coefficient was smaller than 2.8% in the range of
117–652 U/L (n = 30).
Emotional, physical, and sexual trauma
Emotional, physical, and sexual traumas were measured
by means of the Traumatic Experiences Checklist (TEC), a
26-item self-reported questionnaire with good reliability
and validity (Nijenhuis et al., 2002). The scores for the pres-
ence of both emotional trauma (emotional neglect and emo-
tional abuse in various settings) and sexual trauma (sexual
harassment and sexual abuse in various settings) are based
on six items. The scores for the presence of physical abuse
in various settings are based on three items. For all three
types of interpersonal trauma a dichotomous score (yes/no)
was calculated.
Procedure
Candidate participants were invited for an initial informa-
tive session and subsequently to select dates appropriate for
testing. Because of the influence of estradiol on the HPA
axis (Van Veen et al., 2008), women using oral contracep-
tives had to be tested in their gap-week. Women not on oral
contraceptives had to be tested in the follicular phase of
their menstrual cycle and were, therefore, instructed to
record one menstrual cycle and to contact the researcher
when the second menstruation had started to plan the defi-
nite dates for testing. After the test days were planned and
Table 1. Demographic and clinical characteristics for 18 patients with PNES and 19 healthy controls
Variable Patients (n = 18) Controls (n = 19) Statistics
Mean age (SD) in years 31.6 (10.8) 35.1 (13.5) t(35) = 0.84, p = 0.400
Number of women 11 9 V2(1) = 0.70, p = 0.402
Using contraceptives 6 8 V2(1) = 0.30, p = 0.582
Smokers 6 1 V2(1) = 4.75, p = 0.029a
Taking psychotropic medication 9 0 V2(1) = 12.55, p < 0.001b
Paroxetine 4
Risperidone 1
Fluoxetine 2
Oxazepam 1
Sertraline 1
Temazepam 1
Valproic acid 1
Flurazepam 1
Citalopram 1
Participants reporting interpersonal trauma 11 5 V2(1) = 4.56, p = 0.033a
Sexual 7 2 V2(1) = 4.04, p = 0.044a
Emotional 8 4 V2(1) = 2.31, p = 0.129
Physical 6 3 V2(1) = 1.55, p = 0.214
Current comorbid psychopathology 11 0
None 7 19
Mood disorder 3
Anxiety disorders
Panic disorder 3
Agoraphobia 3
Social phobia 3
Generalized anxiety disorder 3
Obsessive compulsive disorder 1
Somatoform disorders
Pain disorder 1
Somatization disorder 1
Hypochondrias 1
Mean age (SD) at onset seizures 26.6 (12.3) –
Disease duration in years (SD) 5.3 (5.5) –
Number of patients reporting seizures 1 h Preceding sampling
Day 1
Cortisol awakening response 0 –
Basal diurnal cortisol 3 –
Day 2 1 –
ap < 0.05; bp < 0.001.
PNES, psychogenic nonepileptic seizures; SD, standard deviation.
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participants had provided informed consent, all participants
were administered a semistructured diagnostic interview by
author P.B. and two trained psychology master students to
screen for DSM-IV axis I disorders (American Psychiatric
Association, 1994; assessed using the MINI: Mini-Interna-
tional Neuropsychiatric Interview, Sheehan et al., 1998;
Van Vliet & de Beurs, 2007). In addition, the trauma ques-
tionnaire was administered. Next, participants were
informed about the necessity of strictly following the proce-
dures and the time schedule for saliva sampling to obtain
valuable data. They were instructed to contact the principal
investigator to postpone the test in case of a febrile illness
within 3 days before the test. In addition, they were asked
not to perform strenuous physical exercise and to avoid
stressful situations as much as possible on these 2 days.
Finally they had to write down their activities and the occur-
rence of seizures during the hour before saliva sampling on
the test days. For each saliva sample, participants were
asked to place the cotton wad from a Salivette saliva collec-
tion tube in their mouth until the cotton roll was saturated,
and to subsequently keep the tube containing the wad prela-
beled with date and time in the refrigerator. For the awaken-
ing samples subjects were instructed to start saliva sampling
immediately at awakening. Subjects were instructed to com-
plete the early morning sampling before breakfast and possi-
ble medicine intake to avoid contamination of saliva with
food or drinks. They were asked not to brush their teeth
before completing the saliva sample 60 min after awaken-
ing. In addition, participants were instructed not to eat,
drink, or smoke 15 min before sampling. All instructions
were given both verbally and in writing.
Participants received financial incentives for their partici-
pation in this study. The protocol was conducted in accor-
dance with the declaration of Helsinki and approved by the
medical ethical committee of the Leiden University Medical
Centre (LUMC).
Statistics
Outliers in cortisol were defined as values that deviated
>2.58 standard deviations (SDs; i.e., the 99th percentile)
from the group mean per assessment. For patients 0.9% and
for HCs 1.1% of the total amount of cortisol samples was
removed. Missing data including outliers (patients 1.2%;
HCs 2.5%) were interpolated linearly by using the partici-
pant’s preceding and following salivary cortisol values, and
modeling the average curve from the participants’ group
over these values for that point in time. Subsequently, to
normalize distributions, cortisol levels were subjected to
natural log transformation before analyses. Separate
repeated-measures analyses of variance (ANOVA rm) were
conducted for the CAR, for the basal diurnal cortisol, and
for post-DST cortisol, each with time (salivary time points)
as within-subject factor and group (patients, HCs) as
between-subject factor. For the CAR and post-DST cortisol
we controlled for the time of awakening (ToA) on days 1
and 2, respectively, by adding this variable to the analysis as
a covariate. In the case of significant group effects, we
controlled for depression, psychotropic medication, and
smoking by repeating the analysis for (1) a subgroup of
patients without a current depression; (2) a subgroup of
patients not on psychotropic medication; (3) nonsmoking
participants; and (4) nonsmoking, nondepressed participants
not on psychotropic medication. To test whether group dif-
ferences in cortisol could be attributed to seizures in
patients, analyses were repeated for those patients not
reporting seizures one hour before saliva sampling. Finally,
to investigate whether cortisol effects were particularly pro-
nounced for those patients who reported sexual trauma, we
conducted an additional three-group analysis with post hoc
least significant difference (LSD) analyses comparing
PNES patients with and without sexual trauma reports and
HCs without sexual trauma reports.
a-Amylase was investigated to test whether possible
group differences in cortisol levels were accompanied by
concomitant group differences in SNS activation. Outliers
in basal diurnal a-amylase were defined as values that devi-
ated >2.58 SD from the group mean per assessment. For
patients 2.4% and for HCs 3.0% of the samples were
removed. Missing data including outliers (patients 3.2%;
HCs 3.0%) were interpolated linearly. To normalize distri-
butions, a-amylase levels were subjected to natural log
transformation before analyses. An ANOVA rm was con-
ducted for basal diurnal a-amylase, with time (salivary time
points) as within-subject factor, and group (patients, HCs)
as between-subject factor.
All statistical analyses described employed a two-tailed
alpha of 0.05. Statistical analysis was performed using the
Statistical Package for the Social Sciences (SPSS, Chicago,
IL, U.S.A.) 16.0 forWindows.
Results
Cortisol awakening response (CAR)
To investigate possible group effects in the CAR, we con-
ducted a two-way ANOVA rm for the morning cortisol lev-
els, with time (five assessment points from awakening until
60 min after awakening) as within-subject factor and group
(patients, HCs) as between-subject factor. Results showed a
significant effect for time [F(4,32) = 6.13, p = 0.001] but
not for group [F(1,35) = 1.21, p = 0.279], or time · group
[F(4,32) = 2.14, p = 0.099]. These effects for group did not
alter when adding ToA on day 1 (ToA1) as a covariate to
this analysis (Group [F(1,33) = 1.04, p = 0.315]; time ·
group [F(4,30) = 2.02, p = 0.116]; ToA1 [F(1,33) = 0.15,
p = 0.704]). Therefore, groups did not differ significantly
with respect to the CAR.
Post dexamethasone suppression test (DST) cortisol
To investigate possible group effects in negative corti-
sol feedback by the DST, a two-way ANOVA rm was
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conducted for the post-DST cortisol levels, with time
(seven assessment points from awakening until 60 min
after awakening and at 16:00 h and 22:00 h) as within-
subject factor and group (patients, HCs) as between-sub-
ject factor. Results showed significant main effects for
both time [F(6,30) = 8.59, p < 0.001] and group
[F(1,35) = 4.90, p = 0.033 – see Fig. 1]. The time ·
group interaction was not significant [F(6,30) = 0.16,
p = 0.984]. These results for group did not change when
adding ToA on day 2 (ToA2) as a covariate to this analy-
sis (group [F(1,33) = 5.41, p = 0.026]; time · group
[F(6,28) = 0.15, p = 0.987]; ToA2 [F(1,33) = 0.49,
p = 0.488]). ToA2 was, therefore, excluded from the
subsequent analyses. This main effect for group remained
significant when excluding patients with depression
(remaining N patients = 15; N controls = 19; group
[F (1,35) = 4.90, p = 0.033]); remained a statistical trend
when excluding patients taking psychotropic medication
(N patients = 9; N controls = 19; group [F(1,26) = 3.86,
p = 0.060]); but did not remain significant when
excluding smoking participants (N patients = 12; N
controls = 18; group [F(1,28) = 1.01, p = 0.325]). There-
fore, we cannot conclude that post-DST cortisol levels are
specifically effected for patients with PNES.
Basal diurnal cortisol
To investigate possible group effects in basal diurnal cor-
tisol levels, we conducted a two-way ANOVA rm for the
salivary basal diurnal cortisol, with time (seven assessment
points from 10:00 h until 22:00 h) as within-subject factor,
and group (patients, HCs) as between-subject factor. Results
showed significant main effects for time [F(6,30) = 22.60,
p < 0.001] and Group1 [F(1,35) = 8.89, p = 0.005] and
most importantly a significant time · group interaction
[F(6,30) = 3.07, p = 0.018 – see Fig. 1]. The time · group
effect for basal diurnal cortisol remained significant when
repeating these analyses for (1) a subgroup of patients with-
out a current depression (N patients = 15; time · group
[F(6,27) = 3.16, p = 0.018]); (2) a subgroup of patients not
taking psychotropic medication (N patients = 9; N con-
trols = 19; time · group [F(6,21) = 2.82, p = 0.036]);
(3) a subgroup without smoking participants (N patients =
12; N controls = 18; time · group [F(6,23) = 3.24,
p = 0.019]). In addition, this effect remained a statistical
trend, even when repeating this analysis for the small sub-
group of nondepressed, nonsmoking participants who were
not using psychotropic medication (N patients = 6; N
controls = 18; time · group [F(6,17) = 2.34, p = 0.079]).
Post hoc F testing indicated, that PNES patients displayed
higher basal cortisol at 12:00 h [F(1,35) = 5.88, p = 0.021],
14:00 h [F(1,35) = 6.21, p = 0.018], 16:00 h [F(1,35) =
Figure 1.
The left panel shows the basal salivary cortisol concentrations of day 1 on a logarithmic scale. The right panel shows the post–dexa-
methasone suppression test (DST) salivary cortisol concentrations of day 2 on a logarithmic scale. Groups did not differ significantly
on salivary cortisol awakening response (CAR; at awakening, +15 min., +30 min., +45 min., +60 min.). Patients with psychogenic
nonepileptic seizures (PNES) had higher basal diurnal cortisol levels (10:00 h, 12:00 h, 14:00 h, 16:00 h, 18:00 h, 20:00 h, and 22:00 h
see *). Post-DST cortisol levels (awakening, +15 min., +30 min., +45 min., +60 min., 4 p.m., and 10 p.m.) were increased in patients
with PNES, but this group effect disappeared when controlling for smoking and psychotropic medication. [Correction made after
online publication 6 Nov 2009: images for figures 1 and 2 switched]
Epilepsia ILAE
1We found the same group effect when conducting an ANOVA with
area under the curve (AUC) with respect to ground [(AUCg);
F(1,35) = 10.37, p = 0.003); for more details see Pruessner et al., 2003,
formula 2]
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9.85, p = 0.003], 18:00 h [F(1,35) = 10.29, p = 0.003] and
20:00 h [F(1,35) = 11.63, p = 0.002]; (other p > 0.106).
To check whether these increased basal diurnal cortisol
levels in patients with PNES were not related to current sei-
zures, we repeated the latter tests for the 15 patients not
reporting seizures one hour prior to sampling. Results
showed that the group effects remained significant at all
time points: 12:00 h [F(1,32) = 6.06, p = 0.019], 14:00 h
[F(1,32) = 5.60, p = 0.024], 16:00 h [F(1,32) = 8.38,
p = 0.007], 18:00 h [F(1,32) = 8.73, p = 0.006] and
20:00 h [F(1,32) = 9.75, p = 0.004]; (other p > 0.098),
indicating that the higher basal diurnal cortisol in patients
with PNES was not attributable to current seizures.
To test our second hypothesis that this effect would be
particularly pronounced in PNES patients who experienced
sexual trauma, an additional analysis for the five basal diur-
nal cortisol sample points on which groups differed (12:00
h, 14:00 h, 16:00 h, 18:00 h, 20:00 h) was conducted. A two
way ANOVA rm, with time (five assessment points) as
within-subject factor and group [patients with sexual trauma
(n = 7), patients without sexual trauma (n = 11), and HCs
without sexual trauma (n = 17; see Table 1)] as between-
subject factor showed a main effect for group
[F(2,32) = 9.11, p = 0.001], and a statistical trend toward
significance for time · group [F(8,60) = 1.90, p = 0.077;
see Fig. 2]. Post hoc LSD analyses indicated that the HC
group had significantly lower basal diurnal cortisol rates as
compared to patients with sexual trauma (p < 0.001); as
well as patients without sexual trauma (p = 0.021). Further-
more, post hoc LSD analyses indicated a trend toward sig-
nificance (p = 0.067) for the difference in basal diurnal
cortisol between patients with and without a history of sex-
ual trauma.
Therefore, patients with PNES displayed heightened
basal HPA-axis activity compared to HCs, and this effect
was particularly pronounced in those patients reporting sex-
ual trauma.
a-Amylase
In order to investigate whether the group effects in basal
cortisol levels were associated with concomitant group
effects in SNS activity, we conducted a two-way ANOVA
rm for saliva basal diurnal a-amylase levels, with time
(seven assessment points from 10:00 h until 22:00 h) as
within-subject factor, and group (patients, HCs) as between-
subject factors. Results showed that there was a significant
main effect for time [F(6,30) = 5.45, p = 0.001], but that
there were no significant effects for group (all p > 0.211),
indicating that patients’ increased HPA-axis activity was
not accompanied by concomitant group differences in SNS
activation.
Discussion
The main purpose of the present study was to investigate
HPA-axis activity in patients with PNES compared to age-
and gender-matched healthy controls (HCs).
Patients’ basal cortisol levels were augmented in the
afternoon and evening. Previous reports of increased HPA-
axis activity in patients with PNES also indicated higher
levels of afternoon and evening cortisol (Tunca et al.,
2000). In the latter study, however, the increased cortisol
levels were related to seizures. Here, we show that the
increased basal cortisol levels in patients with PNES
occurred independent of the acute presence of seizures. In
addition, we found that the increased basal cortisol levels
could not be explained by factors such as increased physical
activity or acute psychological stress, as indicated by the
absence of concomitant group differences in sAA, which is
predictive of SNS activity (see Granger et al., 2007 and
Rohleder & Nater, 2009, for reviews). Finally, the enhanced
basal HPA-axis activity could not be attributed to current
depression, use of psychotropic medication, or smoking.
Based on these findings, it seems justified to conclude
that our patients with PNES showed basal diurnal hyper-
cortisolism.
There were no significant group differences in CAR, but
in line with previous findings (Tunca et al.,1996) our
patients with PNES seemed to show somewhat increased
post-DST cortisol. Tunca et al. (1996) did not, however,
Figure 2.
Basal diurnal salivary cortisol concentrations of day 1 on a loga-
rithmic scale. Healthy controls (n = 17) differed significantly
from both patients with (n = 7) and without (n = 11) sexual
trauma on basal diurnal cortisol levels. In addition, patients with
sexual trauma showed increased cortisol levels as compared to
patients who did not report sex trauma. [Correction made
after online publication 6 Nov 2009: images for figures 1 and 2
switched]
Epilepsia ILAE
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control for psychotropic medication and smoking, and when
we adjusted for these factors our post-DST effects disap-
peared.
Our second aim was to test whether the increased HPA-
axis activity would be particularly pronounced in trauma-
tized patients with PNES. Based on previous findings of
increased threat vigilance in PNES patients who reported
sexual trauma (Bakvis et al., 2009), we predicted higher
cortisol levels in PNES patients with self-reported sexual
trauma compared to patients without self-reported sexual
trauma. Interestingly, the PNES patients in the present study
reported significantly more sexual trauma compared to the
HCs, but no group differences were found in the reports of
emotional and physical trauma history, which may be
interpreted as supporting the critical role of sexual trauma in
PNES. Cortisol analyses indeed specified that whereas
both PNES patients with and without a history of sexual
trauma showed increased basal cortisol levels compared to
HCs, these findings were more pronounced for the
traumatized patients (p = 0.067). This result is in line with a
previous finding in patients with depression showing
increased cortisol levels only in traumatized depressed
patients compared to nontraumatized depressed patients
(Heim et al., 2000b).
Relating our findings of increased HPA-axis activity
in patients with PNES to other relevant stress-related
disorders suggests that PNES show little overlap with
posttraumatic stress disorder (PTSD).2 In a systematic
review and meta-analysis on basal cortisol levels in
adult patients with PTSD, Meewisse et al. (2007)
reported lower basal afternoon cortisol in female PTSD
patients, particular in those patients reporting sexual or
physical trauma. In addition, cortisol hypersuppression
following DST (for a review see De Kloet et al., 2006)
and increased noradrenergic activity (e.g., Southwick
et al., 1999; Yehuda, 2001) have been reported in most
studies in patients with PTSD. Similar signs of hypocor-
tisolism have also been observed in stress-related bodily
disorders, such as burnout, chronic fatigue, fibromyalgia,
and chronic pelvic pain (see Heim et al., 2000a for a
review). Our findings of hypercortisolism in PNES
patients may more resemble previous findings in
patients with a primary dissociative disorder. Increased
basal 24-h urine cortisol was found in 46 patients with
dissociative identity disorder (DID) compared to HCs
(Simeon et al., 2007). Post-DST cortisol was also
increased in these DID patients as well as in nine
patients with depersonalization disorder (Simeon et al.,
2001). Based on this scarce evidence, one might hypoth-
esize that the HPA-axis hyperactivity in PNES patients
shares more overlap with dissociative disorder than with
PTSD. This notion is in accordance with previous
suggestions that PNES might share some common
underlying mechanism with dissociative disorder (Kuyk
et al., 1996; Roelofs et al., 2002; Kihlstrom, 2005;
Brown et al., 2007).
Some strengths and limitations of the present study
should be considered. A strength of the present study is that
all patients were diagnosed using the gold standard: an ictal
video-EEG registration of a typical seizure in order to con-
firm the absence of epileptiform activity, making PNES
diagnosis maximally reliable (e.g., Reuber & Elger, 2003).
Another strong point of this study is that relevant factors
affecting the HPA axis, such as age, gender, menstrual
cycle, contraceptives, smoking, current depression, and psy-
chotropic medication were controlled for. On the other
hand, although our sample size (n = 18) was comparable to
that of other clinical studies, we had only a small subgroup
of nondepressed, nonsmoking, and unmedicated patients
(n = 6). Therefore, this study needs to be replicated in a lar-
ger sample of patients with PNES. This might also offer an
opportunity to further differentiate subgroups of PNES
patients with respect to seizure-type or with respect to early
childhood versus adulthood trauma. To further specifica-
tion, it would be interesting to also include a control group
of traumatized healthy participants. Another limitation of
the study is that interpersonal trauma rates were based on a
self-report questionnaire and were not verified using inde-
pendent sources.
In conclusion, the results of the present study imply that
PNES are associated with basal hypercortisolism, which
was particularly pronounced in traumatized patients with
PNES. The increased basal cortisol levels were not related
to current seizures, and there were no concomitant group
differences in SNS activity. It, therefore, seems unlikely that
the increased HPA-axis activity was merely due to group
differences in current physical or acute psychological stress
factors, but rather posits a relevant neurobiologic marker for
this stress-related disorder.
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